Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Legend Biotech Corp ADR (NQ: LEGN ) 46.85 +3.30 (+7.58%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,667,106 Open 44.57 Bid (Size) 46.30 (1) Ask (Size) 47.20 (3) Prev. Close 43.55 Today's Range 44.00 - 47.45 52wk Range 38.60 - 70.78 Shares Outstanding 308,456,852 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Peering Into Legend Biotech's Recent Short Interest September 06, 2024 Via Benzinga Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock August 28, 2024 Via Benzinga Performance YTD -20.73% -20.73% 1 Month -17.84% -17.84% 3 Month +4.90% +4.90% 6 Month -16.47% -16.47% 1 Year -31.10% -31.10% More News Read More Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 20, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Looking Into Legend Biotech's Recent Short Interest August 16, 2024 Via Benzinga Beyond The Numbers: 15 Analysts Discuss Legend Biotech Stock August 12, 2024 Via Benzinga LEGN Stock Earnings: Legend Biotech Beats EPS, Beats Revenue for Q2 2024 August 09, 2024 Via InvestorPlace The Latest Analyst Ratings For Legend Biotech July 15, 2024 Via Benzinga Assessing Legend Biotech: Insights From 15 Financial Analysts June 21, 2024 Via Benzinga Unveiling 18 Analyst Insights On Legend Biotech June 04, 2024 Via Benzinga Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights August 09, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors August 08, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation? August 01, 2024 Via Benzinga Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 July 26, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio? July 21, 2024 Via Benzinga Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal July 20, 2024 Via Talk Markets Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday July 18, 2024 Via Benzinga CPI Data Sparks Rally in Biotech Stocks July 15, 2024 Via MarketBeat Topics ETFs Economy Exposures Interest Rates Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results July 10, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients July 02, 2024 Via Benzinga Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma July 02, 2024 From Legend Biotech USA Inc. Via GlobeNewswire Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst June 17, 2024 Via Benzinga Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? June 09, 2024 Via Benzinga Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA June 03, 2024 From Legend Biotech Via Business Wire Legend Biotech to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Legend Biotech Corporation Via Business Wire Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA May 23, 2024 From Legend Biotech Corporation Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.